Recruiting NCT06360627
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Computed Tomography.
- Who it may be relevant to
- Registry conditions: Radiation Exposure, Lung Embolism, Lung Cancer, Pneumonia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Interventions
- Radiation Computed Tomography
Computed Tomography CHEST
Primary outcome measures
- Dose Reduction by new scanner [Time frame: through study completion, an average of 1 year]
- stable Image Quality in reduced dose scans [Time frame: through study completion, an average of 1 year]
Eligibility criteria
Inclusion criteria
- CT SCAN for pulmonary nodule detection/follow up
- CT SCAN for pneumonia detection/follow up
Exclusion criteria
- under 18
- BMI over 30
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
Switzerland · 1 center
- University Hospital Zurich - Diagnostic Radiology — Zurich
Identifiers
NCT: NCT06360627 · 2022_D0008